Clinical Trial Update: Therapy With an Oxytocin Adjunct for Major Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on oxytocin adjunct therapy for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Oxytocin adjunct therapy (oxytocin)

Snippet

Sponsor: Concordia University, Montreal | Conditions: Depressive Disorder | Phase 2 | Status: COMPLETED